↑ parent activity group ·
research dossier →

ST JUDE CHILDRENS FOUNDATION

· EIN · stjude.org
profile · synthesized from sources

St. Jude Children’s Research Hospital is a specialty research hospital dedicated to advancing cures and prevention for pediatric catastrophic diseases, primarily childhood cancer, blood disorders, and neurological diseases. It provides treatment, housing, and food to patients and their families at no cost, funded primarily by generous donors. The hospital also conducts extensive research and shares its breakthroughs globally to improve survival rates worldwide.

named programs · 9 · from sources

what they call their work

Cancer Predisposition Program
A program focused on precision medicine, including clinical genomic diagnostic and pharmacogenomic services.
Global Initiative for Childhood Cancer
A multimillion-dollar investment in collaboration with the WHO to improve global survival rates for six common forms of childhood cancer from 20% to 60% by 2030.
Global Medicine Distribution Platform
A multimillion-dollar platform in collaboration with the WHO and international organizations to distribute an uninterrupted supply of anti-cancer drugs for childhood cancer treatment in low- and middle-income countries.
Pediatric Translational Neuroscience Initiative
An initiative to advance cures for children with catastrophic neurological diseases, including the Center for Experimental Neurotherapeutics and the Center for Pediatric Neurological Disease Research.
Project SPARC
A clinical improvement process to strengthen the quality and safety culture across all aspects of patient care.
St. Jude Global
A global initiative to improve survival rates of children with cancer and other catastrophic diseases worldwide through sharing knowledge, technology, and organizational skills, especially in low- and middle-income countries.
St. Jude Pediatric Cancer Genome Project
A research project focused on revolutionizing how cancer is treated worldwide, underway since 2010.
St. Jude Research Collaboratives program
A program to drive scientific collaboration across campus, the U.S., and globally.
Translational Immunology and Immunotherapy Initiative (TI3)
A program to strengthen cancer immunotherapy through research and development.
activities · 2 groups

what they do

  • Cancer Patient Support Services 3 activities
    • Global Childhood Cancer Survival Advocacy
      Works to increase global survival rates for six common childhood cancers from 20% to 60% by 2030.
    • Global Health Initiatives and Capacity Building
      Implements a strategic plan to influence global understanding and treatment of childhood cancer, sickle cell disease, neurological disorders, and infectious diseases. This includes leading the development of a global drug distribution program, expanding the St. Jude Graduate School of Biomedical Sciences, and operating the St. Jude Global Alliance with over 400 member institutions to facilitate collaboration, research, knowledge sharing, and training of practitioners globally.
    • Pediatric Disease Research
      Conducts extensive research on pediatric diseases, including cancers, blood disorders, neurological disorders, and infectious diseases. This includes leading clinical trials, analyzing structural variants in pediatric cancer, developing proteome atlases for neurodegenerative diseases, and researching long-term effects of cancer treatment. The organization has contributed to increasing the overall childhood cancer survival rate in the U.S. from 20% in 1962 to over 80% currently, and has achieved a 94% survival rate for acute lymphoblastic leukemia (ALL) and an 85% survival rate for average risk medulloblastoma.
  • Mobile and Temporary Medical Clinics 1 activity
    • Pediatric Treatment and Care
      Provides free treatment, travel, housing, and food to families of patients with pediatric diseases, including over 90 types of childhood cancers, blood disorders, neurological disorders, and infectious diseases. The hospital treats over 8,000 people annually and operates with 73 licensed beds, primarily for outpatients, and provides housing for over 300 families.
relationships · 19

who they work with

  • ALSAC Partner — ALSAC is the fundraising and awareness organization for St. Jude Children’s Research Hospital.
  • ALSAC Partner — Fundraising and awareness organization for St. Jude Children’s Research Hospital, responsible for fundraising, public engagement, and board governance.
  • ALSAC (American Lebanese Syrian Associated Charities) Partner — Founded by Danny Thomas in 1957 to be the fundraising and awareness organization for St. Jude Children’s Research Hospital, with the sole mission to raise funds and awareness necessary to operate and maintain the hospital.
  • American Lebanese Syrian Associated Charities (ALSAC) Partner — Exists solely to raise funds and awareness necessary to run St. Jude.
  • Baton Rouge, Louisiana Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • Charlotte, North Carolina Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • Deloitte Partner — Audits St. Jude and ALSAC's annual reports.
  • Global Alliance Partner — Collaborative network to improve cure rates for pediatric cancer and blood diseases worldwide
  • Huntsville, Alabama Partner — Hosts a St. Jude clinic location providing specialized pediatric care.
  • Johnson City, Tennessee Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • Peoria, Illinois Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • Shreveport, Louisiana Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • Springfield, Missouri Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • St. Jude Global Network — Core component of St. Jude's global outreach and clinical expansion efforts
  • St. Jude Global Network — Initiative to improve global survival rates for common childhood cancers by 2030.
  • Tulsa, Oklahoma Partner — Affiliate location providing expert, compassionate care in partnership with St. Jude.
  • Washington University Partner — Collaborated on the Pediatric Cancer Genome Project.
  • World Health Organization Partner — Named St. Jude its first and only Collaborating Centre for Childhood Cancer in March 2018; collaborates on a global medicine distribution platform.
  • World Health Organization (WHO) Partner — Announced a five-year collaboration to transform cancer care globally.